Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of High Risk Renal Tumors: A Groupwide Phase II Study

NCT00335556 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00335556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00335556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of High Risk Renal Tumors: A Groupwide Phase II Study
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2006
Completion date
Not reported
Enrollment
291 (actual)
Sites
187

Conditions

As the registry lists them; a condition with its own page is linked.

childhood renal cell carcinoma, clear cell renal cell carcinoma, clear cell sarcoma of the kidney, papillary renal cell carcinoma, rhabdoid tumor of the kidney, stage i renal cell cancer, stage i renal wilms tumor, stage ii renal cell cancer, stage ii renal wilms tumor, stage iii renal cell cancer, stage iii renal wilms tumor, stage iv renal cell cancer, stage iv renal wilms tumor